Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Tokyo  >  Ono Pharmaceutical Co., Ltd.    4528   JP3197600004

ONO PHARMACEUTICAL CO., LTD.

(4528)
  Report  
 SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Financials (JPY)
Sales 2020 297 B
EBIT 2020 70 135 M
Net income 2020 55 712 M
Finance 2020 90 408 M
Yield 2020 2,20%
Sales 2021 316 B
EBIT 2021 78 584 M
Net income 2021 62 495 M
Finance 2021 126 B
Yield 2021 2,41%
P/E ratio 2020 19,3x
P/E ratio 2021 17,3x
EV / Sales2020 3,14x
EV / Sales2021 2,83x
Capitalization 1 021 B
More Financials
Company
ONO PHARMACEUTICAL CO., LTD. is a Japan-based company primarily engaged in the manufacture and sale of pharmaceuticals. The Company operates in one business segment. The Pharmaceutical segment involves in the manufacture and sale of drugs for medical and general use. The Company also involves in... 
Sector
Pharmaceuticals
Calendar
02/04Earnings Release
More about the company
Surperformance© ratings of Ono Pharmaceutical Co., Lt
Trading Rating : Investor Rating :
More Ratings
Latest news on ONO PHARMACEUTICAL CO., LT
11/01ONO PHARMACEUTICAL : Announces Completion of Cancellation of Treasury Shares
AQ
10/01BRISTOL-MYERS SQUIBB COMPANY : - Opdivo Demonstrates Statistically Significant O..
AQ
09/27ONO PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
FA
07/26ONO PHARMACEUTICAL : Drug firm to seek talks with Nobel laureate Honjo with new ..
AQ
07/22BRISTOL MYERS SQUIBB : Bayer, Bristol-Myers Squibb and Ono Pharmaceutical enter ..
AQ
07/12FORTY SEVEN : and Ono Pharmaceutical Co., Ltd. Sign Regional License Agreement t..
AQ
07/12ONO PHARMACEUTICAL : Selected for MSCI Japan ESG Select Leaders Index, an Index ..
AQ
06/27ONO PHARMACEUTICAL : Rafael Pharmaceuticals, Ono Pharmaceutical to accelerate cl..
AQ
06/26ONO PHARMACEUTICAL : Rafael Pharmaceuticals Enters into Out-Licensing Agreement ..
AQ
06/14ONO PHARMACEUTICAL : Nobel winner Honjo to make decision on license pay suit in ..
AQ
06/04ONO PHARMACEUTICAL : Announces Status of Acquisition of Own Shares
AQ
04/10ONO PHARMACEUTICAL : Nobel winner Honjo, pharmaceutical company spar over licens..
AQ
03/29ONO PHARMACEUTICAL : pumps cash into U.K. immuno-oncology R&D effort
AQ
03/27ONO PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend
FA
03/08ONO PHARMACEUTICAL : Helsinn initiates two new global Phase III studies with ana..
AQ
More news
News in other languages on ONO PHARMACEUTICAL CO., LT
09/27ONO PHARMACEUTICAL CO., LTD. : Ex-dividend day for interim dividend
07/18DPA-AFX-ÜBERBLICK : UNTERNEHMEN vom 18.07.2019 - 15.15 Uhr
07/18Bayer hofft auf neues Einsatzfeld für Krebsmedikament Stivarga
03/27ONO PHARMACEUTICAL CO., LTD. : Ex-dividend day for final dividend
2018TOKYO STOCK EXCHANGE : Tokyo finit en hausse de 0,10%
More news
Analyst Recommendations on ONO PHARMACEUTICAL CO., LT
More recommendations
Sector news : Generic Pharmaceuticals
11/12ABBVIE : Sells $30 Billion of Bonds -- 2nd Update
DJ
11/12AbbVie Prepares Large Bond Sale -- Update
DJ
11/12ABBVIE : Prepares Large Bond Sale to Fund Allergan Purchase
DJ
11/12MYLAN N : and Pfizer Say Combined -Upjohn to Be Called Viatris
DJ
11/12ALLERGAN : Form 8.3 - Allergan Plc
DJ
More sector news : Generic Pharmaceuticals
Technical analysis trends ONO PHARMACEUTICAL CO., LT
Short TermMid-TermLong Term
TrendsBullishBullishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 13
Average target price 2 404,17  JPY
Last Close Price 2 109,00  JPY
Spread / Highest target 51,7%
Spread / Average Target 14,0%
Spread / Lowest Target -14,7%
EPS Revisions
Managers
NameTitle
Gyo Sagara President & Representative Director
Kei Sano Director & General Manager-Operations
Kazuhito Kawabata Director & Managing Executive Officer
Hiroshi Awata Director & Executive Vice President
Isao Ono Director & Managing Executive Officer
Sector and Competitors